https://www.selleckchem.com/pr....oducts/remodelin.htm
In-vivo ocular pharmacokinetics indicated a significant improvement in ophthalmic bioavailability of epinephrine (active form of DV). F8 was non-irritant to the eyes and showed a successful, continuous and superior ability to reduce IOP compared to DV-AqS in rabbits. In conclusion, our developed system could be an appropriate substitute to the conventional DV eye preparations in the management of elevated IOP.The prevalence of degenerative diseases increases with age. Furthermore, various factors tend to trigger cells injury, thereby,
Like
Comment
Share
